Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches

Area of Science:

• Psychiatry
• Precision Medicine
• Pharmacogenomics
• Artificial Intelligence
• Machine Learning

Background:

• Precision psychiatry integrates psychiatry, precision medicine, and pharmacogenomics for tailored patient treatment.
• Advancements in AI and machine learning are crucial for identifying biomarkers and genetic factors in psychiatric disorders.
• Neuroimaging and multi-omics data are increasingly utilized in precision psychiatry research.

Purpose of the Study:

• To review the latest developments in precision psychiatry research.
• To highlight the application of AI and machine learning techniques in analyzing multi-omics and neuroimaging data.
• To discuss biomarkers, genetic loci, limitations, and future directions in the field.

Main Methods:

• Review of precision psychiatry and pharmacogenomics studies.
• Focus on artificial intelligence and machine learning approaches (deep learning, neural networks).
• Integration of multi-omics and neuroimaging data analysis.

Main Results:

• AI/ML techniques are used for treatment, prognosis, and diagnosis prediction in psychiatry.
• Discovery of potential biomarkers and genetic loci associated with psychiatric diseases and treatments.
• Identification of limitations in current precision psychiatry and pharmacogenomics studies.

Conclusions:

• Precision psychiatry, powered by AI/ML, is foundational for accurate psychiatric treatment.
• Continued research is needed to overcome limitations and advance personalized psychiatric care.
• Future directions involve refining AI/ML models and integrating diverse data sources for enhanced precision.